CBD May Better Prevent Seizures Than Stop Them
Researchers studied cannabidiol (CBD) in a lab rat model of malformation of cortical development (MCD), a brain development problem linked to hard-to-treat epilepsy.
This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
Researchers studied cannabidiol (CBD) in a lab rat model of malformation of cortical development (MCD), a brain development problem linked to hard-to-treat epilepsy.
This study looked at children with a rare brain abnormality called focal cortical dysplasia type 1 (FCD1), which can cause epilepsy that does not respond to medicine.
This study looked at add-on treatment with perampanel in very young children with drug-resistant epilepsy.
This study tested ES-481, a new add-on anti-seizure medicine, in adults with drug-resistant epilepsy.
Researchers combined results from randomized, double-blind studies that tested two add-on seizure medicines, lacosamide (LCM) and brivaracetam (BRV), in adults and older teens with drug-resistant focal epilepsy.
This report describes one premature newborn boy in the Netherlands who had hard-to-control seizures.
This paper was a structured narrative review, not a new clinical trial.
This paper combined results from earlier studies to look for factors linked with response to vagus nerve stimulation (VNS) in people with drug-resistant epilepsy.
Researchers looked at whether checking the quality of pulse signals from a wearable light sensor, called photoplethysmography (PPG), could improve seizure detection.